Artículo especial
Enfermedad relacionada con IgG4: ¿es el rituximab la mejor estrategia terapéutica en los casos refractarios a terapia convencional? Resultados de una revisión sistemática
IgG4-related disease: Is rituximab the best therapeutic strategy for cases refractory to conventional therapy? Results of a systematic review
Leído
11379
Vecesse ha leído el artículo
2913
Total PDF
8466
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 10 | 18 | 77 | 95 |
| 2025 9 | 0 | 67 | 67 |
| 2025 8 | 0 | 62 | 62 |
| 2025 7 | 0 | 69 | 69 |
| 2025 6 | 7 | 37 | 44 |
| 2025 5 | 215 | 58 | 273 |
| 2025 4 | 209 | 59 | 268 |
| 2025 3 | 206 | 55 | 261 |
| 2025 2 | 239 | 50 | 289 |
| 2025 1 | 293 | 62 | 355 |
| 2024 12 | 251 | 49 | 300 |
| 2024 11 | 237 | 72 | 309 |
| 2024 10 | 229 | 54 | 283 |
| 2024 9 | 205 | 34 | 239 |
| 2024 8 | 217 | 40 | 257 |
| 2024 7 | 144 | 43 | 187 |
| 2024 6 | 218 | 50 | 268 |
| 2024 5 | 177 | 48 | 225 |
| 2024 4 | 172 | 36 | 208 |
| 2024 3 | 156 | 43 | 199 |
| 2024 2 | 141 | 25 | 166 |
| 2024 1 | 148 | 35 | 183 |
| 2023 12 | 109 | 32 | 141 |
| 2023 11 | 110 | 48 | 158 |
| 2023 10 | 135 | 33 | 168 |
| 2023 9 | 342 | 34 | 376 |
| 2023 8 | 90 | 26 | 116 |
| 2023 7 | 110 | 38 | 148 |
| 2023 6 | 125 | 34 | 159 |
| 2023 5 | 116 | 30 | 146 |
| 2023 4 | 87 | 21 | 108 |
| 2023 3 | 108 | 48 | 156 |
| 2023 2 | 123 | 43 | 166 |
| 2022 1 | 84 | 31 | 115 |
| 2022 12 | 121 | 32 | 153 |
| 2022 11 | 115 | 69 | 184 |
| 2022 10 | 101 | 60 | 161 |
| 2022 9 | 123 | 68 | 191 |
| 2022 8 | 83 | 51 | 134 |
| 2022 7 | 108 | 50 | 158 |
| 2022 6 | 172 | 43 | 215 |
| 2022 5 | 166 | 41 | 207 |
| 2022 4 | 268 | 66 | 334 |
| 2022 3 | 234 | 54 | 288 |
| 2022 2 | 194 | 55 | 249 |
| 2021 1 | 187 | 37 | 224 |
| 2021 12 | 166 | 80 | 246 |
| 2021 11 | 199 | 64 | 263 |
| 2021 10 | 138 | 52 | 190 |
| 2021 9 | 76 | 57 | 133 |
| 2021 8 | 58 | 35 | 93 |
| 2021 7 | 72 | 32 | 104 |
| 2021 6 | 89 | 43 | 132 |
| 2021 5 | 98 | 51 | 149 |
| 2021 4 | 176 | 109 | 285 |
| 2021 3 | 116 | 40 | 156 |
| 2021 2 | 89 | 44 | 133 |
| 2020 1 | 65 | 45 | 110 |
| 2020 12 | 66 | 30 | 96 |
| 2020 11 | 100 | 30 | 130 |
| 2020 10 | 26 | 4 | 30 |
| 2020 9 | 1 | 2 | 3 |
| 2020 8 | 5 | 6 | 11 |
| 2020 7 | 4 | 6 | 10 |
| 2020 6 | 9 | 8 | 17 |
| 2020 4 | 1 | 0 | 1 |
| 2019 9 | 1 | 0 | 1 |
| 2019 3 | 3 | 0 | 3 |
| 2019 2 | 1 | 0 | 1 |
| 2019 1 | 14 | 6 | 20 |
Mostrar todo
